PEStore

Venture Capital

Floating Point

Floating Point backs early-stage and high-growth companies, typically pre-profit, from Boston, United States. It states a focus on healthcare & life sciences, financial services, transportation & logistics and energy & utilities.

Capital raised$15macross 8 SEC-filed vehicles
Most recent fund2025filing since 2019
HeadquartersBoston, United States
Largest single fund$8m

Stated investment criteria

What Floating Point says it buys

Read from Floating Point’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

People listed on its team page101

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Floating Point to consider any particular business, and nothing on this page is represented as being for sale.

SEC filings

What Floating Point has raised

From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.

Vehicles filed8
Total capital raised$15m
Largest single vehicle$8m
Filing history2019 to 2025
Smallest accepted commitmentNone stated
Filed fromNEW YORK

Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.

Regulatory record

How Floating Point is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised7 · $293m gross
SEC adviser numberCRD 310440

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies Floating Point lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
Altana
Altana (Series A)
Ataraxis (Series A)
Ataraxis AI
Bonside
Bridger (Seed)
CloudCruise
Cofactr
Commons Clinic
Commons Clinic (Seed)
Dandelion Health
Elion
Firefly Health
Floodbase
Floodbase (Pre-seed)
Hedges
Heirloomcarbon
Hioscar
Integrated Projects
Ledgebrook
Meetradial
Mending
Mevo
Mevo (Series A)
Nevoya
Odin
Oscar (Founding)
Oya Care
Pearl Health
Photon
QuoteWell
Remedy Scientific
RenewaFi
SetPoint
Setpoint (Series B)
Shopper
Startcoral
Sun Day (Incubation)
Sun Day Carwash
TimberEye
Tive
Unlimited ETFs
Vend Park
VotingWorks
Wheeler Bio
bridgergp.com
catenaclearing.io
cliftonapi.com
flyatlas.ai
greaterindustries.co
hntrbrk.com
junokids.com
withclutch.com

Compiled from Floating Point’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Floating Point?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other venture capital investors active in healthcare & life sciences.